Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VNN1 | O95497 | 13/20 | 0.59 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.35 |
| ▸ | CTSG | P08311 | 1/20 | 0.35 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.35 |
| ▸ | CMA1 | P23946 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA7 | P43166 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pantothenic Acid, Racemic SCHEMBL482267 | 0.81 | VNN1 (0.61) | VNN1PTGS1KCNH2 | |
| Pantothenic Acid SCHEMBL482266 | 0.81 | VNN1 (0.61) | VNN1PTGS1KCNH2 | |
| SCHEMBL3754662 | 0.80 | PTGS1 (0.55) | VNN1PTGS1KCNH2CA12CA14 | |
| SCHEMBL8039883 | 0.79 | PTGS1 (0.54) | VNN1PTGS1KCNH2 | |
| SCHEMBL29250117 | 0.79 | PTGS1 (0.54) | VNN1PTGS1KCNH2 | |
| SCHEMBL8417455 | 0.79 | VNN1 (0.68) | VNN1PTGS1KCNH2 | |
| SCHEMBL8417457 | 0.79 | VNN1 (0.68) | VNN1PTGS1KCNH2 | |
| SCHEMBL28332287 | 0.78 | PTGS1 (0.52) | VNN1PTGS1KCNH2 | |
| Alcohol SCHEMBL27660651 | 0.77 | VNN1 (0.65) | VNN1PTGS1KCNH2 | |
| SCHEMBL28416351 | 0.77 | PTGS1 (0.51) | VNN1PTGS1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2411352-A2 | ANTIVIRAL COMPOUNDS AND USES THEREOF | Abbott Laboratories (US) | 2012-02-01 | — | — | EP | disclosed |
| WO-2010111436-A2 | ANTIVIRAL COMPOUNDS AND USES THEREOF | ABBOTT LABORATORIES (US) | 2010-09-30 | — | — | WO | disclosed |